Apollo Endosurgery Inc (NASDAQ:APEN)

6.64
Delayed Data
As of May 21
 +0.10 / +1.53%
Today’s Change
3.55
Today|||52-Week Range
8.50
+18.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues5.1M1.6M64.9M64.3M
 
 
 
 
 
Cost of Goods Sold----23.4M22.1M
 
 
 
Depreciation And Amortization216.1K467.0K9.1M9.7M
 
 
 
 
 
 
Operating ExpensesGross Income----32.4M32.5M
 
 
 
General Expenses22.7M12.0M49.5M54.9M
 
 
 
 
 
Research And Development18.1M8.5M7.8M8.3M
 
 
 
 
 
Total Operating Expenses22.9M12.5M82.0M86.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.8M-10.9M-17.1M-22.4M
 
 
 
 
 
Extraordinary Credit1.3M850.0K0.000.00
 
 
 
Extraordinary Charge0.000.00-3.6M0.00
 
 
Interest Expense On Debt0.000.0018.3M4.5M
 
 
 
Other Expenses20.0050.00-1.9M-41.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.6M-10.0M-40.8M-27.0M
 
 
 
 
 
Income Taxes0.000.00-387.0K-304.0K
 
 
 
Net Income-16.6M-10.0M-41.2M-27.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS215.0K334.2K389.5K13.6M
 
 
 
 
 
Shares To Calculate EPS Diluted215.0K334.2K389.5K13.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$77.01-$30.04-$105.69-$2.01
 
 
 
 
 
EPS Diluted-$77.01-$30.04-$105.69-$2.01